Starton Therapeutics Inc. — Form D

Starton Therapeutics Inc. of PARAMUS, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-26. The offering totals $78K, of which $78K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
PEDRO LICHTINGERDirectorPARAMUS, NJ
PEDRO LICHTINGERExecutive OfficerPARAMUS, NJ
LITSA PERPERIDISPromoterPARAMUS, NJ
Nitin KaushalDirectorKelowna, A1
Scott KahnExecutive OfficerParamus, NJ
Mohamad HusseinDirectorMelbourne Beach, FL
Eric BaumDirectorCharlotte, NC
Roy WaldronDirectorFort Lauderdale, FL
Asher Chanan-KhanDirectorJacksonville, FL
Pedro Lichtinger WaismanDirectorSunny Isles Beach, FL
Pedro Lichtinger WaismanExecutive OfficerSunny Isles Beach, FL
Kenneth AndersonDirectorWellesley, MA
Moses DodoDirectorCoral Gables, FL
Fotios PlakogiannisDirectorWhitestone, NY
Jamie OliverExecutive OfficerRaleigh, NC
Cidnee VaykovichDirectorNew York, NY
Cidnee VaykovichExecutive OfficerNew York, NY
Keith DarraghExecutive OfficerParamus, NJ
Pedro WaismanDirectorParamus, NJ
Pedro WaismanExecutive OfficerParamus, NJ
ROY WALDONDirectorFORT LAUDERDALE, FL
ROMAN ROGOLDirectorNEW YORK, NY
Nintin KaushalDirectorNew York, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2024-10-22D$2.1M$2.1M
2023-10-13D$971K$971K
2023-04-13D$1.4M$1.4M
2023-01-25D$1.0M$1.0M
2022-02-16D$1.1M$1.1M
2021-11-22D$1.1M$1.1M
2020-01-13D$2.0M
2018-07-02D$767K

More